174 related articles for article (PubMed ID: 11976850)
1. Classification of hypervascularized lesions in CE MR imaging of the breast.
Baum F; Fischer U; Vosshenrich R; Grabbe E
Eur Radiol; 2002 May; 12(5):1087-92. PubMed ID: 11976850
[TBL] [Abstract][Full Text] [Related]
2. MR imaging in probably benign lesions (BI-RADS category 3) of the breast.
Gökalp G; Topal U
Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732
[TBL] [Abstract][Full Text] [Related]
3. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
Cilotti A; Iacconi C; Marini C; Moretti M; Mazzotta D; Traino C; Naccarato AG; Piagneri V; Giaconi C; Bevilacqua G; Bartolozzi C
Radiol Med; 2007 Mar; 112(2):272-86. PubMed ID: 17361370
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced 3.0-T breast MRI for characterization of breast lesions: increased specificity by using vascular maps.
Schmitz AC; Peters NH; Veldhuis WB; Gallardo AM; van Diest PJ; Stapper G; van Hillegersberg R; Mali WP; van den Bosch MA
Eur Radiol; 2008 Feb; 18(2):355-64. PubMed ID: 17882425
[TBL] [Abstract][Full Text] [Related]
5. Role of breast MR imaging for predicting malignancy of histologically borderline lesions diagnosed at core needle biopsy: prospective evaluation.
Pediconi F; Padula S; Dominelli V; Luciani M; Telesca M; Casali V; Kirchin MA; Passariello R; Catalano C
Radiology; 2010 Dec; 257(3):653-61. PubMed ID: 20884914
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
[TBL] [Abstract][Full Text] [Related]
7. Three-phase dynamic breast magnetic resonance imaging with two-way subtraction.
Choi N; Han BK; Choe YH; Kim HS
J Comput Assist Tomogr; 2005; 29(6):834-41. PubMed ID: 16272861
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of MR elastography in addition to contrast-enhanced MR imaging of the breast-initial clinical results.
Siegmann KC; Xydeas T; Sinkus R; Kraemer B; Vogel U; Claussen CD
Eur Radiol; 2010 Feb; 20(2):318-25. PubMed ID: 19727753
[TBL] [Abstract][Full Text] [Related]
9. Frequency of malignancy seen in probably benign lesions at contrast-enhanced breast MR imaging: findings from ACRIN 6667.
Weinstein SP; Hanna LG; Gatsonis C; Schnall MD; Rosen MA; Lehman CD
Radiology; 2010 Jun; 255(3):731-7. PubMed ID: 20501712
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI.
Alamo L; Fischer U
Eur Radiol; 2001; 11(6):970-7. PubMed ID: 11419173
[TBL] [Abstract][Full Text] [Related]
12. Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound.
Vassiou K; Kanavou T; Vlychou M; Poultsidi A; Athanasiou E; Arvanitis DL; Fezoulidis IV
Eur J Radiol; 2009 Apr; 70(1):69-76. PubMed ID: 18295425
[TBL] [Abstract][Full Text] [Related]
13. Contrast-enhanced cone-beam breast-CT (CBBCT): clinical performance compared to mammography and MRI.
Wienbeck S; Fischer U; Luftner-Nagel S; Lotz J; Uhlig J
Eur Radiol; 2018 Sep; 28(9):3731-3741. PubMed ID: 29594402
[TBL] [Abstract][Full Text] [Related]
14. Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images.
Yabuuchi H; Matsuo Y; Okafuji T; Kamitani T; Soeda H; Setoguchi T; Sakai S; Hatakenaka M; Kubo M; Sadanaga N; Yamamoto H; Honda H
J Magn Reson Imaging; 2008 Nov; 28(5):1157-65. PubMed ID: 18972357
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of probably benign lesions (BI-RADS 3 category) in breast MR imaging.
Hauth E; Umutlu L; Kümmel S; Kimmig R; Forsting M
Breast J; 2010; 16(3):297-304. PubMed ID: 20565469
[TBL] [Abstract][Full Text] [Related]
16. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
[TBL] [Abstract][Full Text] [Related]
17. Frequency of malignancy in lesions classified as probably benign after dynamic contrast-enhanced breast MRI examination.
Sadowski EA; Kelcz F
J Magn Reson Imaging; 2005 May; 21(5):556-64. PubMed ID: 15834907
[TBL] [Abstract][Full Text] [Related]
18. Observer variability and applicability of BI-RADS terminology for breast MR imaging: invasive carcinomas as focal masses.
Kim SJ; Morris EA; Liberman L; Ballon DJ; La Trenta LR; Hadar O; Abramson A; Dershaw DD
AJR Am J Roentgenol; 2001 Sep; 177(3):551-7. PubMed ID: 11517046
[TBL] [Abstract][Full Text] [Related]
19. Typical atypical findings on dynamic MRI of the breast.
Kurz KD; Roy S; Mödder U; Skaane P; Saleh A
Eur J Radiol; 2010 Nov; 76(2):195-210. PubMed ID: 19726148
[TBL] [Abstract][Full Text] [Related]
20. CE-Magnetic Resonance Mammography for the evaluation of the contralateral breast in patients with diagnosed breast cancer.
Pediconi F; Venditti F; Padula S; Roselli A; Moriconi E; Giacomelli L; Catalano C; Passariello R
Radiol Med; 2005; 110(1-2):61-8. PubMed ID: 16163140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
